<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Antithrombin III is a well-known coagulation inhibitor </plain></SENT>
<SENT sid="1" pm="."><plain>Its heterozygous deficit is demonstrated through concentrations reduced about by 50 p </plain></SENT>
<SENT sid="2" pm="."><plain>100 </plain></SENT>
<SENT sid="3" pm="."><plain>On a clinical level, about 40 p </plain></SENT>
<SENT sid="4" pm="."><plain>100 to 70 p </plain></SENT>
<SENT sid="5" pm="."><plain>100 patients present with <z:hpo ids='HP_0002625'>deep venous thrombosis</z:hpo> (visceral on the whole) and <z:hpo ids='HP_0002204'>pulmonary embolisms</z:hpo> from puberty </plain></SENT>
<SENT sid="6" pm="."><plain>There are both qualitative and quantitative deficits, these appearing to be mostly frequent </plain></SENT>
<SENT sid="7" pm="."><plain>Only calculation of activity in the presence of <z:chebi fb="5" ids="28304">heparin</z:chebi> (co-factor of <z:chebi fb="5" ids="28304">heparin</z:chebi>) enables to diagnose these two types of deficits </plain></SENT>
<SENT sid="8" pm="."><plain>Treatment performed includes both AT III concentrated agents and <z:chebi fb="5" ids="28304">heparin</z:chebi> in severe cases </plain></SENT>
<SENT sid="9" pm="."><plain>Recurrences prevention is performed thanks to antivitamins K </plain></SENT>
<SENT sid="10" pm="."><plain>If surgical treatment or delivery, a prevention of any incidents thanks to a vicarious therapy (AT III concentrated agent) is to be used </plain></SENT>
</text></document>